65,437 trials
Hepatitis C · Opiate Dependence
Primary: Number of Participants With a Sustained Virologic Response (SVR) — 7; 1 participants
Major Depressive Disorder · Depression
Primary: Change in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score From Randomization to End of Treatment. — -12.1; -11.8; -11.3; -11.2 units on a scale — p=1.000
Hemophilia A
Primary: Mean Transformed Annualized Bleed Rate Estimates From Each of the 1-year Prophylaxis Regimens — 1.61; 1.46 (bleeds/year)^(1/2) — p=0.6016
Coronary Artery Disease
Primary: Stent Thrombosis (Definite and Probable) Rate as Defined by ARC (Academic Research Constortium). — 0.81 percentage of participants
Hepatitis C, Chronic
Primary: Incidence of Serious Adverse Events (SAEs) and/or Clinically Significant Adverse Events (AEs) — 33.6; 1.9 percentage of participants
Pain
Primary: Discomfort Level and Patient Satisfaction With the Preparation Protocol and Intravitreal Injection — 2.1; 2.09; 1.7; 2.0 units on a scale
Japanese Encephalitis
Primary: Safety and Tolerability up to Day 56 — 58.9; 56.6 percentage of participants with AEs
Major Depressive Disorder · Depression
Primary: Change in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score From Randomization to End of Treatment. — -11.7; -11.6 units on a scale — p=0.944
Contraception
Primary: OC Prescriptions by Treatment Group and Prescribing Medical Specialists — 244; 331; 929; 2213 Prescribing physicians
Healthy
Primary: Corneal Fluorescein Staining Type at Baseline — 1.7 Units on a scale
Sclerotic Graft Versus Host Disease · Imatinib Mesylate
Primary: Percent Change in Absolute Range of Motion (ROM) From Baseline to 6 Months — 94; 35; 16; 21 Percent change from baseline
Smoking Cessation · Tobacco Use Cessation · Health Behavior
Primary: Smoking Status at Follow up — 7; 24 percentage of participants — p=<0.05
Pediculosis
Primary: Cmax for Spinosyn A — NA ng/mL
Brain and Central Nervous System Tumors
Primary: Safety of Treatment — 1; 1; 5; 1 participants
Healthy Subjects · Partial Denture Wearers · Caries
Primary: Mean Percentage Surface Microhardness Recovery (%SMHR) of Enamel Specimens Exposed to NaF/Carbopol Toothpaste (1400 ppmF), NaF Toothpaste (1350ppmF) Compared to…